Stock DBVT DBV TECHNOLOGIES S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company DBV Technologies S.A. Nasdaq

Equities

DBVT

US23306J1016

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-30 EDT 		5-day change 1st Jan Change
0.6616 USD -4.28% Intraday chart for DBV Technologies S.A. -2.71% -30.56%
04-23 European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading MT
04-22 European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading MT

Business Summary

DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.

Number of employees: 105

Sales per Business

EUR in Million2022Weight2023Weight Delta
Epicutaneous Immunotherapy Products
100.0 %
5 100.0 % 15 100.0 % +215.64%

Sales per region

EUR in Million2022Weight2023Weight Delta
France
100.0 %
5 100.0 % 15 100.0 % +215.64%

Managers

Managers TitleAgeSince
Daniel Tassé CEO
 Chief Executive Officer 64 18-11-28
Virginie Simone Jeanine Verrechia DFI
 Director of Finance/CFO 54 11-05
Pharis Mohideen CTO
 Chief Tech/Sci/R&D Officer 59 19-07-21
Pascale Ehouarn CTO
 Chief Tech/Sci/R&D Officer - 05-12-31
Katie Matthews IRC
 Investor Relations Contact - -
Pascal Wotling PRN
 Corporate Officer/Principal - 20-03-31
Michele F. Robertson LAW
 General Counsel - 21-02-21
Caroline Daniere HRO
 Human Resources Officer 50 19-09-01

Members of the board

Members of the board TitleAgeSince
Timothy Morris BRD
 Director/Board Member 61 21-02-28
Michel de Rosen CHM
 Chairman 73 18-06-21
Don Soland BRD
 Director/Board Member 65 15-03-05
Michael Goller BRD
 Director/Board Member 49 15-10-20
Daniel Tassé CEO
 Chief Executive Officer 64 18-11-28
Maïlys Ferrère BRD
 Director/Board Member 60 16-06-20
Danièle Guyot-Caparros BRD
 Director/Board Member 64 22-10-02
Julie O'Neill BRD
 Director/Board Member 58 17-06-14
Ravi Rao BRD
 Director/Board Member 55 21-05-18
Adora Ndu BRD
 Director/Board Member 43 21-05-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 96,250,954 86,727,703 ( 90.11 %) 149,793 ( 0.1556 %) 90.11 %

Shareholders

NameEquities%Valuation
Baker Bros. Advisors LP
24.37 %
23,498,350 24.37 % 34 M $
Venrock Associates
9.644 %
9,300,000 9.644 % 13 M $
BPIFrance Investissement SAS
7.417 %
7,151,863 7.417 % 10 M $
Bpifrance Participations SA /PRIVATE EQUITY/
7.182 %
6,925,700 7.182 % 10 M $
Braidwell LP
3.422 %
3,300,000 3.422 % 5 M $
DBV TECHNOLOGIES
0.1553 %
149,793 0.1553 % 215 324 $
Lyxor International Asset Management SAS
0.1513 %
145,886 0.1513 % 209 708 $
Pharis Mohideen
0.0852 %
82,194 0.0852 % 118 152 $
La Française Asset Management SAS
0.0570 %
55,000 0.0570 % 79 061 $
Amundi Asset Management SA (Investment Management)
0.0455 %
43,899 0.0455 % 63 104 $
NameEquities%Valuation
Baker Bros. Advisors LP
7.578 %
14,614,264 7.578 % 11 M $
Braidwell LP
4.067 %
7,843,285 4.067 % 6 M $
Yiheng Capital Management LP
2.718 %
5,241,564 2.718 % 4 M $
Point72 Asset Management LP
1.614 %
3,112,500 1.614 % 2 M $
Vivo Capital LLC
1.405 %
2,708,875 1.405 % 2 M $
Threadneedle Asset Management Ltd.
0.5771 %
1,113,070 0.5771 % 833 689 $
Morgan Stanley & Co. International Plc
0.3421 %
659,726 0.3421 % 494 135 $
Millennium Management LLC
0.3272 %
630,965 0.3272 % 472 593 $
Boxer Capital LLC
0.2593 %
500,000 0.2593 % 374 500 $
Pivotal Bioventure Partners Investment Advisor LLC
0.1923 %
370,950 0.1923 % 277 842 $

Holdings

NameEquities%Valuation
DBV TECHNOLOGIES
0.16%
 149,793 0.16% 215,324 $

Company contact information

DBV Technologies SA

177-181, avenue Pierre Brossolette

92120, Montrouge

+33 1 55 42 78 78

http://www.dbv-technologies.com
address DBV Technologies S.A.(DBVT)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Ratings for DBV Technologies S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.244 EUR
Average target price
4.783 EUR
Spread / Average Target
+284.51%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
MERCK KGAA Stock Merck KGaA
+3.37% 69.25B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.55% 9B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.75% 4.96B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+42.38% 4.47B
YUHAN CORPORATION Stock Yuhan Corporation
+5.23% 3.9B
INDIVIOR PLC Stock Indivior PLC
+20.00% 2.45B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-19.05% 2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.72% 2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+11.13% 2.02B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DBV Stock
  4. DBVT Stock
  5. Company DBV Technologies S.A.